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Abstract: A series of novel homopiperazine derivatives were synthesized and characterized using 1H 
NMR, LC MS, IR and elemental analysis data. These novel molecules were evaluated for their 
antiproliferative activity against Reh, leukemia cells using trypan blue and MTT assays. All the 
molecules showed cytotoxicity with IC50 values between 50-100 µM as calculated by trypan blue 
assay and greater than 100 µM as calculated by MTT assay. Compound 6b with 3,5-dinitro 
substituents on phenyl ring of the aryl carboxamide moiety attached to homopiperazine ring showed 
good activity with IC50 value of 41 µM. 
 
 
Introduction 
 
Cancer remains the leading cause of death 
in the World and as a result there is a 
pressing need for novel and effective 
treatments. One of the characteristic of 
cancer cells, that differs from their normal 
counterparts in a number of biochemical 
processes, particularly during the control 
of cell growth and division. Among 
different types of cancers, leukemia is one 
of the major causes of cancer related 
deaths [1,2]. 
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Hence, the identification of novel, efficient 
and less toxic anticancer agents remains an 
important and challenging task in cancer 
biology. 
Synthetic heterocyclic compounds have 
been used extensively for drug 
development and the treatment of diseases 
including cancer [3]. Piperazines have 
been widely used in biological screening 
resulting In numerous applications [4] and 
constitutes an attractive pharmacological 
scaffold present in several drugs. This 
small and rigid heterocyclic backbone 
could act on various pharmacological 
targets. Especially, piperazine nucleus 
could be found in a broad range of 
biological active compounds displaying 
anticancer [5], antibacterial [6], antifungal 
[7], antimalarial, antipsychotic agents [8], 
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HIV protease inhibitors [9], 
antidepressants [10] and anti-inflammatory 
activities [11]. Homopiperazines having 
similar structure as piperazine with one 
extra carbon atom in the ring have also 
shown various biological activities [12-
15]. Earlier we reported the anticancer 
activity of benzhydryl piperazine 
derivatives against human cancer cell lines 
[16]. In continuation of our work, herein 
we report the synthesis and anticancer 
activity of benzhydryl homopiperazine 
derivatives. 
 
 
Materials and Methods 
 
Chemistry: Infrared (IR) spectra were 
recorded using a Jasco FTIR-4100 
spectrometer in the wave number range of 
4000-400 cm-1.  Nuclear magnetic 
resonance (1H NMR) spectra were 
recorded on a Bruker AM 400 MHz 
spectrometer using DMSO-d6 as solvent 
and tetramethylsilane as an internal 
standard. The chemical shifts are 
expressed in δ and the following 
abbreviations are used: s (singlet), d 
(doublet), t (triplet), q (quartet) and m 
(multiplet). Mass and purity were recorded 
on a LC-MSD-Trap-XCT. Elemental 
(CHNS) analyses were obtained on Vario 
EL III Elementar. The purity of the 
compounds was checked by thin layer 
chromatography (TLC). Silica gel column 
chromatography was performed using 
Merck 7734 silica gel (60-120 mesh) and 
Merck made TLC plates. All the reagents 
and chemicals were from Sigma Aldrich 
Chemicals Pvt Ltd. 
 
Synthesis of 1-benzhydryl-4-(substituted 
phenylcarbonyl)-1,4-diazepane 
derivatives 6(a-f) 
1-Benzhydryl-1,4-diazepane derivatives 
6(a-f) were synthesised by the method 
summarized in Scheme 1. Initially the 
compound 2, benzhydrol was synthesised 
by reduction of benzophenone 1 using 
sodium borohydride and achieved 90% 
yield. Compound 2was subsequently 
treated with thionyl chloride to give 
benzhydryl chloride 3, which was directly 
treated with homopiperazine 4 and 
anhydrous potassium carbonate using 
dimethyl formamide as a solvent at 80 oC 
to give the target key intermediates 1-
benzhydryl-1,4-diazepane 5. Nucleophilic 
substitution reaction of compound 5 with 
different substituted benzoyl chlorides 
yielded the target compounds 6(a-f). 
 
Synthesis of benzhydrol (2) 
A solution of substituted benzophenone 
(20.0 g, 109 mmol) in methanol was taken 
and cooled to 0-5 oC. Sodium borohydride 
(8.28 g, 219.5 mmol) was added to the 
solution and stirred for 5 hr at room 
temperature. Upon completion, the solvent 
was removed under reduced pressure and 
residue was taken in water and extracted 
with ethyl acetate. Finally water wash was 
given to the organic layer and dried with 
anhydrous sodium sulphate. The solvent 
was evaporated to get benzhydrol.  
 
Synthesis of benzhydryl chloride (3) 
A solution of substituted benzhydrol (16.0 
g, 86.8 mmol) in dry dichloromethane was 
taken and cooled to 0-5 oC. Thionyl 
chloride (30.7 g, 258 mmol) was added to 
the solution and stirred for 4-5 hr at 0-10 
oC. Upon completion, the solvent was 
removed under reduced pressure and 
residue was taken in dichloromethane for 
the removal of excess thionyl chloride to 
get benzhydryl chloride.  
 
Synthesis of 1-benzhydryl-1,4-diazepane 
(5) 
To a solution of homopiperazine 4 (5.0 g, 
49.9 mmol) in dimethyl formamide, 
anhydrous potassium carbonate (20.7 g, 
149.7 mmol) was added followed by the 
addition benzhydryl chloride (9.1 g, 44.9 
mmol) and the reaction mixture was heated 
to 80 oC for 8 hr. Completion of the 
reaction was monitored by TLC. After 
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completion, the solvent was removed 
under reduced pressure and residue was 
taken in water and extracted with ethyl 
acetate. Finally, water wash was given to 
the organic layer and dried with anhydrous 
sodium sulphate. The solvent was 
evaporated to get crude product, which 
was purified by column chromatography 
over silica gel (60-120 mesh) using 
chloroform: methanol (9:1) as an eluent. 
 
General procedure for synthesis of 1-
benzhydryl-4-(substituted 
phenylcarbonyl)-1,4-diazepane 
derivatives 6(a-f) 
A solution of 1-benzhydryl-1,4-diazepane 
(5) (1.0 eq) in dry dichloromethane was 
mixed. Triethylamine (3.0 eq) was added 
to the reaction mixture and stirred for 10 
min, and then different benzoyl chlorides 
(1.0 eq) were added. The reaction mixture 
was stirred for 5-6 hr at room temperature, 
and monitored by TLC. Upon completion, 
the solvent was removed under reduced 
pressure and residue was taken in water 
and extracted with ethyl acetate. The 
organic layer was washed with 10% 
ammonium chloride solution and finally 
water wash was given to the organic layer 
and dried with anhydrous sodium sulphate. 
The solvent was evaporated to get crude 
product, which was purified by column 
chromatography over silica gel (60-120 
mesh)  using hexane:ethyl acetate (8:2) as 
an eluent. 
 
Synthesis of (4-benzhydryl-1,4-
diazepan-1-yl)(3-
methoxyphenyl)methanone (6a) 
The product 6a was obtained by reaction 
of 1-benzhydryl-1,4-diazepane (5) (0.5 g, 
1.88 mmol), 3-methoxybenzoyl chloride 
(0.32 g, 1.88 mmol) and triethylamine 
(0.57 g, 5.64 mmol) in dichloromethane 
using the general experimental procedure 
as described. 1H NMR (DMSO-d6, 400 
MHz) δ: 7.92 (t, 1H, Ar-H), 7.83 (d, 2H, 
Ar-H), 7.48 (t, 4H, Ar-H), 7.31 (m, 2H, 
Ar-H), 7.18 (m, 4H, Ar-H), 6.98 (s, 1H, 
Ar-H), 4.74 (s, 1H, -CH-), 3.89 (s, 3H, -
OCH3), 2.93 (m, 4H, -CH2-), 2.78 (d, 4H, -
CH2-), 1.52-1.63 (m, 2H, -CH2-).  MS 
(ESI, + ion): m/z = 401.3. IR (KBr, cm-1): 
1681, 1372, 1164. Elemental Analysis: 
Found: C, 78.07; H, 6.97; N, 7.07; 
Calculated for C26H28N2O2: C, 77.97; H, 
7.05; N, 6.99. 
 
Synthesis of (4-benzhydryl-1,4-
diazepan-1-yl)(3,5-
dinitrophenyl)methanone (6b) 
The product 6b was obtained by reaction 
of 1-benzhydryl-1,4-diazepane (5) (0.5 g, 
1.88 mmol), 3,5-dinitrobenzoyl chloride 
(0.43 g, 1.88 mmol) and triethylamine 
(0.57 g, 5.64 mmol) in dichloromethane 
using the general experimental procedure 
as described. 1H NMR (DMSO-d6, 400 
MHz) δ: 8.42 (s, 1H, Ar-H), 8.19 (s, 2H, 
Ar-H), 7.75 (t, 2H, Ar-H), 7.41 (m, 4H, 
Ar-H), 7.29 (m, 4H, Ar-H), 7.17 (m, 4H, 
Ar-H), 4.86 (s, 1H, -CH-),  2.65 (t, 4H, -
CH2-), 2.53-2.58 (m, 4H, -CH2-), 1.62 (m, 
2H, -CH2-).  MS (ESI, + ion): m/z =462.2. 
IR (KBr, cm-1): 1686, 1368, 1165. 
Elemental Analysis: Found: C, 65.29; H, 
5.37; N, 12.24; Calculated for 
C25H24N4O5: C, 65.21; H, 5.25; N, 12.17. 
 
Synthesis of (4-benzhydryl-1,4-
diazepan-1-yl)(2,6-
difluorophenyl)methanone (6c) 
The product 6c was obtained by reaction 
of 1-benzhydryl-1,4-diazepane (5) (0.5 g, 
1.88 mmol), 2,6-difluorobenzoyl chloride 
(0.33 g, 1.88 mmol) and triethyl-amine 
(0.57 g, 5.64 mmol) in dichloromethane 
using the general experimental procedure 
as described. 1H NMR (DMSO-d6, 400 
MHz) δ: 7.57 (t, 1H, Ar-H), 7.45 (t, 4H, 
Ar-H), 7.32 (m, 2H, Ar-H), 7.21 (t, 4H, 
Ar-H), 7.16 (t, 2H, Ar-H), 4.72 (s, 1H, -
CH-), 2.66 (t, 4H, -CH2-), 2.53 (m, 4H, -
CH2-),  1.52-1.6 (m, 2H, -CH2-).  MS (ESI, 
+ ion): m/z =407.2. IR (KBr, cm-1): 1681, 
1361, 1162. Elemental Analysis: Found: 
C, 74.01; H, 6.07; N, 6.97; Calculated for 
C25H24F2N2O: C, 73.87; H, 5.95; N, 6.89. 
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Synthesis of (4-benzhydryl-1,4-
diazepan-1-yl)(2-
fluorophenyl)methanone (6d) 
The product 6d was obtained by reaction 
of 1-benzhydryl-1,4-diazepane (5) (0.5 g, 
1.88 mmol), 2-fluorobenzoyl chloride 
(0.30 g, 1.88 mmol) and triethylamine 
(0.57 g, 5.64 mmol) in dichloromethane 
using the general experimental procedure 
as described. 1H NMR (DMSO-d6, 400 
MHz) δ: 8.01 (t, 1H, Ar-H), 7.92 (d, 1H, 
Ar-H), 7.85 (d, 2H, Ar-H), 7.42 (m, 4H, 
Ar-H), 7.21-7.29 (t, 4H, Ar-H), 7.1-7.17 (t, 
2H, Ar-H), 4.74 (s, 1H, -CH-), 2.73 (t, 4H, 
-CH2-), 2.62 (m, 4H, -CH2-), 1.65 (m, 2H, 
-CH2-). MS (ESI, + ion): m/z =389.2. IR 
(KBr, cm-1): 1678, 1360, 1160. Elemental 
Analysis: Found: C, 77.42; H, 6.57; N, 
7.27; Calculated for C25H25FN2O: C, 
77.29; H, 6.49; N, 7.21. 
 
Synthesis of (4-benzhydryl-1,4-
diazepan-1-yl)(3-
bromophenyl)methanone (6e) 
The product 6e was obtained by reaction 
of 1-benzhydryl-1,4-diazepane (5) (0.5 g, 
1.88 mmol), 3-bromobenzoyl chloride 
(0.41 g, 1.88 mmol) and triethylamine 
(0.57 g, 5.64 mmol) in dichloromethane 
using the general experimental procedure 
as described. 1H NMR (DMSO-d6, 400 
MHz) δ: 8.15 (s, 1H, Ar-H), 7.92 (d, 1H, 
Ar-H), 7.85 (d, 1H, Ar-H), 7.72 (t, 1H, Ar-
H), 7.42 (m, 4H, Ar-H), 7.2-7.28 (d, 4H, 
Ar-H), 7.13 (m, 2H, Ar-H),  4.83(s, 1H, -
CH-), 2.72 (t, 4H, -CH2-), 2.31 (m, 4H, -
CH2-), 1.74 (m, 2H, -CH2-).  MS (ESI, + 
ion): m/z =450.2. IR (KBr, cm-1): 1678, 
1369, 1158. Elemental Analysis: Found: 
C, 66.92; H, 5.49; N, 6.32; Calculated for 
C25H25BrN2O: C, 66.82; H, 5.61; N, 6.23. 
 
Synthesis of (4-benzhydryl-1,4-
diazepan-1-yl)(phenyl)methanone (6f) 
The product 6f was obtained by reaction of 
1-benzhydryl-1,4-diazepane (5) (0.5 g, 
1.88 mmol), 3-nitrobenzene sulfonyl 
chloride (0.26 g, 1.88 mmol) and 
triethylamine (0.57 g, 5.64 mmol) in 
dichloromethane using the general 
experimental procedure as described. 1H 
NMR (DMSO-d6, 400 MHz) δ: 7.96 (d, 
2H, Ar-H),  7.77 (m, 2H, Ar-H), 7.52 (t, 
1H, Ar-H), 7.48 (d, 4H, Ar-H), 7.27 (t, 4H, 
Ar-H), 7.14 (m, 2H, Ar-H),  4.72 (s, 1H, -
CH-), 2.62 (t, 4H, -CH2-), 2.44 (m, 4H, -
CH2-), 1.64 (m, 2H, -CH2-).  MS (ESI, + 
ion): m/z =371.1. IR (KBr, cm-1): 1682, 
1367, 1161. Elemental Analysis: Found: 
C, 80.94; H, 6.98; N, 7.67.; Calculated for 
C25H26N2O: C, 81.05; H, 7.07; N, 7.56. 
 
Biology: 
Chemicals and reagents 
 
All the chemicals used were of analytical 
grade and purchased from Sigma–Aldrich, 
USA or from SRL, India. 
 
Cell lines and culture conditions 
 
Reh, a B-cell leukemia cell line, a kind gift 
from Dr. M.R. Lieber, USA, was cultured 
in RPMI 1640 (Sera Lab, UK) containing 
10% FBS (Gibco BRL, USA), 100 U of 
Penicillin G/ml and 100 µg/ml 
streptomycin (Sigma–Aldrich, USA) at 
37°C in a humidified atmosphere 
containing 5% CO2. 
 
Trypan blue dye exclusion assay 
 
The effect of compounds 6 (a-f) on cell 
viability was tested by trypan blue 
exclusion assay [17, 18]. Reh cells were 
cultured at a density of 1 × 105 cells/ml 
and the compounds were added at 
concentrations of 10, 50 and 100 µM after 
24 h.  Cells were harvested at an interval 
of 24 h and resuspended in 0.4% trypan 
blue (Sigma–Aldrich, USA). The live cells 
were counted and IC50 values (50% 
inhibition of cell growth) were estimated 
for 72 h of treatment with the compounds 
(Table 1).  DMSO treated cells were used 
as vehicle control. Experiments were 
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repeated at least 2 independent times and the values obtained were plotted as a graph 
 
N N
O OH Cl
(ii)(i) HN NH
N NH
(iii)
1 2 3
+
5
4
(iv)
O
6(a-f)
R
 
Scheme 1 
Reagents and conditions: (i). NaBH4, Methanol, r.t., 5 hr. (ii). Thionyl chloride, MDC, 0-5 
oC, 4 hr. (iii). K2CO3, DMF, 80 oC, 8 hr. (iv). substituted benzoyl chloride, MDC, TEA, r.t., 
5-6 hr.  
 
MTT assay 
 
The compounds, 6(a-f) were tested for 
their effect on cell proliferation by using 3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenyl 
tetrazolium bromide (MTT) assay [19, 20]. 
Reh cells were cultured (duplicates) in 96-
well plates and compounds were added 
after 24 h, at a concentration of 10, 50 and 
100 µM of  6(a-f).  The cells were 
collected after 24, 48 and 72 h of 
incubation and used for the MTT assay. 
MTT reagent (5 mg/ml, Sigma–Aldrich, 
USA) was added to the cells and incubated 
for 4 h, resulting in formation of an 
insoluble purple colour formazan product. 
This  product was then solubilized using a 
detergent containing 50% N,N-
dimethylformamide (Sigma–Aldrich, 
USA) and 10% of sodium dodecyl 
sulphate (Amresco, USA) and incubated 
for another 2 h. The absorbance was 
measured at 570 nm using a multiwell 
ELISA plate reader (Molecular Devices, 
USA) scanning spectrophotometer. Cells 
treated with DMSO were used as vehicle 
control. The values obtained were plotted 
as % cell proliferation (The percentage of 
cell proliferation was calculated as: ratio of 
OD value of sample/OD value of control x 
100). Each experiment was performed a 
minimum of two independent times and 
the values were plotted as a bar diagram 
with error bars. 
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Figure 1. Dose- and time-dependent effect of 2, 3 series of compounds on cell viability of 
B-cell leukemic cell line, Reh.  A.  Approximately 1 x 105 cells/ml were cultured and 2 
series compounds 6(a-f) were added after 24 h at a concentration of 10, 50 and 100 µM. Cells 
alone and cells treated with DMSO were used as control and vehicle control, respectively. 
After addition of compounds, live cells were counted following staining with trypan blue at 
an interval of 24 h, till the cells reached stationary phase. Data obtained were plotted as a 
graph and error bars are indicated.   
 
 
Figure 2. Determination of effect of compounds 6(a-f) on Reh cells by MTT assay.  A. 
Reh cells, grown for 24 h, were treated with 6(a-f) at a concentration of 10, 50 and 100 µM.  
The cells were collected following 24, 48 and 72 h of treatment and subjected to MTT assay 
as specified in methods. The percentage of DMSO treated (vehicle control) Reh cells were 
considered as 100% and the relative inhibition following treatment with the compounds is 
shown as a bar diagram.  
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Table 1: Chemical structure and IC50 values of the synthesized compounds 6(a-f) on Reh 
cells (as determined based on trypan blue assay). 
 
   
Compound R IC50 in µM 
6a 
OCH3
 
69 
6b 
NO2
NO2 
41 
6c 
F
F
 
75 
6d 
F
 
50 
6e 
Br
 
80 
6f 
 
>100 
 
 
Results and discussion 
 
In the present study, we have synthesised a 
series of novel aryl carboxamide and 
benzhydryl substituted homopiperazine 
derivatives. All the novel molecules were 
charactesised using 1H NMR, LC MS, IR 
and elemental analysis data. Then we have 
investigated the cytotoxic effect of 6(a-f) 
compounds on Reh, a B-cell leukemia cell 
line. Concentrations of 10, 50 and 100 µM 
were used for testing. Cells alone and cells 
with DMSO were used as control and 
vehicle control, respectively. In order to 
determine the cell viability, trypan blue 
assay was performed. Results showed that 
the addition of 6(a-f) compounds showed 
cytotoxicity at 100 µM concentration 
(Figure 1).  All the compounds exhibited 
IC50 values in the range of 50-100µM in 
trypan blue assay (Table 1). These results 
suggest that compounds 6(a-f) induced 
cytotoxicity at higher concentration and 
induced cell death on Reh cells in a time- 
and dose-dependent manner. Compound 
6b with 3,5-dinitro substituents on the 
phenyl ring of the aryl carboxamide 
moiety attached to the homopiperazine 
ring showed good activity compared to all 
the derivatives in the series with an IC50 
value of 41µM. Compound 6f without any 
substituents on the phenyl ring showed 
poor activity with IC50 value of around 
100 µM. 
The effect of compounds 6(a-f) on cell 
proliferation was further tested by using 
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MTT assay. Reh cells were treated with 
10, 50 and 100 µM. The cells were 
harvested after 24, 48 and 72 h of 
treatment and subjected to MTT assay. 
The proliferation of Reh cells was 
determined by the reduction of MTT by 
the metabolic activity of viable cells. 
Results showed that addition of 
compounds 6(a-f) affect the cell 
proliferation (Figure 2) at concentration of 
100 µM. Based on MTT assay, the IC50 
was calculated and; most of them showed 
IC50 values >100 µM. These results 
suggest that the activity depends on the 
substitution on the phenyl ring of aryl 
carboxamide moiety. 
 
Conclusion 
 
In conclusion, a series of novel 
homopiperazine carboxamide derivatives 
were synthesised and evaluated for their 
antiproliferative activity against Reh cells. 
Compound 6b with 3,5-dintro substitution 
on the phenyl ring of the aryl carboxamide 
moiety attached to homopiperazine 
showed good activity. Further 
derivatisation of the key intermediate to 
increase the efficacy and to study the 
structure activity relationship associated 
with the nature and position of the 
substituents on the phenyl ring are 
underway. Further, the study of the 
mechanism of action of these novel 
molecules in inhibition of the proliferation 
of Reh cells is also under progress and the 
results will be reported in future. 
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